PFS Not Established as a Surrogate End Point for OS in Treatment of Ovarian Cancer

This large meta-analysis was found to support the GCIG Fifth Ovarian Cancer Consensus statement that OS is the preferred primary end point.

Source: CancerNetwork - January 31, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news